NVO compared with IQV: revenue, margins and what each company keeps, and the suppliers and customers both name

NVONovo Nordisk A S

Mkt capRevenueRevenue

IQVIqvia Holdings Inc.

Mkt capRevenueRevenue

Compare

NVONovo Nordisk A S

IQVIqvia Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NVO 6

OMEROmerossupplier

LXRXLexicon Pharmaceuticalssupplier

COAGHemab Therapeuticscustomer

VTVTvTv Therapeuticscustomer

2 more · NVO chain ›

Shared 0

No shared counterparties.

Only IQV 1

VSTMVerastemcustomer

Role chip = supplier or customerSource: SEC EDGAR

NVONovo Nordisk A S

40.17▼−0.69%· post 40.22· delayed

Mkt cap$180.6BRevenue—Revenue—

IQVIqvia Holdings Inc.

262.25▲+1.48%· post 262.25· delayed

After hoursNov 3 '26delayed

Mkt cap$42.6BRevenue$4.4BQ3 FY26Revenue$16.3BFY25

Compare

After hoursNov 3 '26delayed

NVONovo Nordisk A S

IQVIqvia Holdings Inc.

40.17▼−0.69%post 40.22delayed

Price

262.25▲+1.48%post 262.25delayed

$180.6B

Mkt cap

$42.6B

—

Revenue

$4.4BQ3 FY26

—

Revenue

$16.3BFY25

NVO40.17▼−0.69%vsIQV262.25▲+1.48%After hoursNov 3 '26delayed